7-week Study With CT-155 in People With Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

September 22, 2022

Study Completion Date

December 12, 2022

Conditions
Schizophrenia
Interventions
DEVICE

CT-155 smartphone app

The CT-155 study app is designed to provide treatment monitoring and educational components of a full treatment cycle with CT-155. This design allows inferences to be made about the usability and acceptability of CT-155. Eligible participants will be enrolled during an in-person clinic visit on Day 1. Participants will then be directed to access the study app and perform tasks each day for the 49-day engagement period.

Trial Locations (10)

10032

CT-155 Study Center, New York

10314

CT-155 study Center, Staten Island

44122

CT-155 Study Center, Beachwood

60611

CT-155 Study Center, Chicago

73112

CT-155 Study Center, Oklahoma City

90230

CT-155 Study Center, Culver City

90631

CT-155 Study Center, La Habra

92408

CT-155 Study Center, San Bernardino

92704

CT-155 Study Center, Santa Ana

92845

CT-155 Study Center, Garden Grove

Sponsors
All Listed Sponsors
lead

Click Therapeutics, Inc.

INDUSTRY

NCT05486312 - 7-week Study With CT-155 in People With Schizophrenia | Biotech Hunter | Biotech Hunter